Cassava Sciences (SAVAW) Short Interest Ratio & Short Volume → Urgent Nvidia Warning (From Altimetry) (Ad) Free SAVAW Stock Alerts $0.42 +0.11 (+35.48%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial Media Cassava Sciences Short Interest DataCurrent Short Volume2,020,000 sharesPrevious Short Volume2,260,000 sharesChange Vs. Previous Month-10.62%Dollar Volume Sold Short$1.58 millionShort Interest Ratio / Days to Cover8.4Last Record DateApril 15, 2024Today's Trading Volume859,916 sharesAverage Trading Volume427,063 sharesToday's Volume Vs. Average201% Short Selling Cassava Sciences ? Sign up to receive the latest short interest report for Cassava Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSAVAW Short Interest Over TimeSAVAW Days to Cover Over TimeSAVAW Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 Cassava Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,020,000 shares $1.58 million -10.6%N/A8.4 $0.78 3/31/20242,260,000 shares $9.11 million +0.9%N/A6 $4.03 3/15/20242,240,000 shares $10.80 million -4.7%N/A5.2 $4.82 2/29/20242,350,000 shares $12.57 million -10.7%N/A4.6 $5.35 2/15/20242,630,000 shares $18.57 million -9.6%N/A4.3 $7.06 1/31/20242,910,000 shares $20.22 million No ChangeN/A3.6 $6.95 SAVAW Short Interest - Frequently Asked Questions What is Cassava Sciences' current short interest? Short interest is the volume of Cassava Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,020,000 shares of SAVAW short. Learn More on Cassava Sciences' current short interest. What is a good short interest ratio for Cassava Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SAVAW shares currently have a short interest ratio of 8.0. Learn More on Cassava Sciences's short interest ratio. Is Cassava Sciences' short interest increasing or decreasing? Cassava Sciences saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 2,020,000 shares, a drop of 10.6% from the previous total of 2,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Cassava Sciences stock? Short selling SAVAW is an investing strategy that aims to generate trading profit from Cassava Sciences as its price is falling. SAVAW shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cassava Sciences? A short squeeze for Cassava Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SAVAW, which in turn drives the price of the stock up even further. How often is Cassava Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SAVAW, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Squeeze Alpha Tau Medical Short Squeeze Apollomics Short Squeeze Artelo Biosciences Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze Carmell Short Squeeze Celularity Short Squeeze Clene Short Squeeze Conduit Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SAVAW) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace